Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Opportunities and challenges using artificial intelligence in ADME/Tox
HTML
Details
Locations
Year:
2019
Type:
article
Source:
Nature Materials
DOI:
10.1038/s41563-019-0332-5
Authors:
Barun Bhhatarai,
W. Patrick Walters,
Cornelis E. C. A. Hop,
Guido Lanza,
Sean Ekins
Institutions:
Relay Therapeutics (United States),
Genentech,
Collaborations Pharmaceuticals (United States)
Language:
English
Topic:
Computational Drug Discovery Methods
Subfield:
Drug Discovery
Field:
Pharmacology, Toxicology and Pharmaceutics
Domain:
Life Sciences
Keywords:
artificial intelligence,
machine learning,
ADME-Tox,
drug discovery,
drug development,
pharmacokinetics,
drug-likeness prediction
show all 7
SDG:
Good health and well-being
Open Access status:
green
Funders:
National Institutes of Health,
National Institute of General Medical Sciences,
National Center for Advancing Translational Sciences
Awards:
Centralized assay datasets for modelling support of small drug discovery organizations,
Biocomputation across distributed private datasets to enhance drug discovery,
G9000213775
OpenAlex ID:
W2935857979
FWCI:
4.754
Cites:
30
Cited by:
130
Related to:
9